Androgen and estrogen dynamics in women with vertebral crush fractures

Christopher Longcope, Rebecca S. Baker, Siu L. Hui, C. Conrad Johnston

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Using constant infusions of [3h]androgen/[14c]estrogen we measured metabolic clearance and production rates and aromatization of androgens to estrogens in post-menopausal women with vertebral crush fractures and compared these results to similar measurements in a similar population of postmenopausal women who did not have vertebral crush fractures. The mean ±SEM values for the metabolic clearance rates of testosterone and estrone, 220±10 and 880±50 1/day per m2, were significantly less in the crush fracture group than the respective mean values in the control group, 280±15 and 1110±70 1/day per m2. The mean concentration of estradiol was higher in the crush fracture group, 18±2 pg/ml, compared to that in the control group, 13±1 pg/ml. However, for the crush fracture group the mean blood production rates of both androstenedione, 0.7±0.1 mg/day, and testosterone, 56±9 μg/day, were significantly less than the respective values in the control group, 1.2±0.2 mg/day and 115±15 μg/day. The production rates for estrone and estradiol were not different for the two groups. In addition the mean value for the fraction of adrostenedione converted to testosterone ([ρ{variant}]BBA.T) was lower in the crush fracture, 0.030±0.002 compared to the control group, 0.041±0.004. Thus the amount of biologically available androgen is less in the vertebral crush fracture group than in the control group. However, since these measurements represent an isolated point temporally removed from major changes in bone morphology, their exact relationship to the crush fracture and osteoporotic process remains uncertain.

Original languageEnglish (US)
Pages (from-to)309-318
Number of pages10
JournalMaturitas
Volume6
Issue number4
DOIs
StatePublished - Dec 1984

Fingerprint

Androgens
Estrogens
Control Groups
Metabolic Clearance Rate
Testosterone
Estrone
Estradiol
Aromatization
Crush Injuries
Androstenedione
Blood Group Antigens
Bone
Bone and Bones
Scanning electron microscopy
Population

Keywords

  • Androgen dynamics
  • Estrogen dynamics
  • Vertebral crush factors

ASJC Scopus subject areas

  • Aging
  • Obstetrics and Gynecology

Cite this

Androgen and estrogen dynamics in women with vertebral crush fractures. / Longcope, Christopher; Baker, Rebecca S.; Hui, Siu L.; Johnston, C. Conrad.

In: Maturitas, Vol. 6, No. 4, 12.1984, p. 309-318.

Research output: Contribution to journalArticle

Longcope, Christopher ; Baker, Rebecca S. ; Hui, Siu L. ; Johnston, C. Conrad. / Androgen and estrogen dynamics in women with vertebral crush fractures. In: Maturitas. 1984 ; Vol. 6, No. 4. pp. 309-318.
@article{d55e62d0ea2c494baf1421c3ac720fe5,
title = "Androgen and estrogen dynamics in women with vertebral crush fractures",
abstract = "Using constant infusions of [3h]androgen/[14c]estrogen we measured metabolic clearance and production rates and aromatization of androgens to estrogens in post-menopausal women with vertebral crush fractures and compared these results to similar measurements in a similar population of postmenopausal women who did not have vertebral crush fractures. The mean ±SEM values for the metabolic clearance rates of testosterone and estrone, 220±10 and 880±50 1/day per m2, were significantly less in the crush fracture group than the respective mean values in the control group, 280±15 and 1110±70 1/day per m2. The mean concentration of estradiol was higher in the crush fracture group, 18±2 pg/ml, compared to that in the control group, 13±1 pg/ml. However, for the crush fracture group the mean blood production rates of both androstenedione, 0.7±0.1 mg/day, and testosterone, 56±9 μg/day, were significantly less than the respective values in the control group, 1.2±0.2 mg/day and 115±15 μg/day. The production rates for estrone and estradiol were not different for the two groups. In addition the mean value for the fraction of adrostenedione converted to testosterone ([ρ{variant}]BBA.T) was lower in the crush fracture, 0.030±0.002 compared to the control group, 0.041±0.004. Thus the amount of biologically available androgen is less in the vertebral crush fracture group than in the control group. However, since these measurements represent an isolated point temporally removed from major changes in bone morphology, their exact relationship to the crush fracture and osteoporotic process remains uncertain.",
keywords = "Androgen dynamics, Estrogen dynamics, Vertebral crush factors",
author = "Christopher Longcope and Baker, {Rebecca S.} and Siu Hui and Johnston, {C. Conrad}",
year = "1984",
doi = "10.1016/0378-5122(84)90002-1",
language = "English",
volume = "6",
pages = "309--318",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Androgen and estrogen dynamics in women with vertebral crush fractures

AU - Longcope, Christopher

AU - Baker, Rebecca S.

AU - Hui, Siu L.

AU - Johnston, C. Conrad

PY - 1984/12

Y1 - 1984/12

N2 - Using constant infusions of [3h]androgen/[14c]estrogen we measured metabolic clearance and production rates and aromatization of androgens to estrogens in post-menopausal women with vertebral crush fractures and compared these results to similar measurements in a similar population of postmenopausal women who did not have vertebral crush fractures. The mean ±SEM values for the metabolic clearance rates of testosterone and estrone, 220±10 and 880±50 1/day per m2, were significantly less in the crush fracture group than the respective mean values in the control group, 280±15 and 1110±70 1/day per m2. The mean concentration of estradiol was higher in the crush fracture group, 18±2 pg/ml, compared to that in the control group, 13±1 pg/ml. However, for the crush fracture group the mean blood production rates of both androstenedione, 0.7±0.1 mg/day, and testosterone, 56±9 μg/day, were significantly less than the respective values in the control group, 1.2±0.2 mg/day and 115±15 μg/day. The production rates for estrone and estradiol were not different for the two groups. In addition the mean value for the fraction of adrostenedione converted to testosterone ([ρ{variant}]BBA.T) was lower in the crush fracture, 0.030±0.002 compared to the control group, 0.041±0.004. Thus the amount of biologically available androgen is less in the vertebral crush fracture group than in the control group. However, since these measurements represent an isolated point temporally removed from major changes in bone morphology, their exact relationship to the crush fracture and osteoporotic process remains uncertain.

AB - Using constant infusions of [3h]androgen/[14c]estrogen we measured metabolic clearance and production rates and aromatization of androgens to estrogens in post-menopausal women with vertebral crush fractures and compared these results to similar measurements in a similar population of postmenopausal women who did not have vertebral crush fractures. The mean ±SEM values for the metabolic clearance rates of testosterone and estrone, 220±10 and 880±50 1/day per m2, were significantly less in the crush fracture group than the respective mean values in the control group, 280±15 and 1110±70 1/day per m2. The mean concentration of estradiol was higher in the crush fracture group, 18±2 pg/ml, compared to that in the control group, 13±1 pg/ml. However, for the crush fracture group the mean blood production rates of both androstenedione, 0.7±0.1 mg/day, and testosterone, 56±9 μg/day, were significantly less than the respective values in the control group, 1.2±0.2 mg/day and 115±15 μg/day. The production rates for estrone and estradiol were not different for the two groups. In addition the mean value for the fraction of adrostenedione converted to testosterone ([ρ{variant}]BBA.T) was lower in the crush fracture, 0.030±0.002 compared to the control group, 0.041±0.004. Thus the amount of biologically available androgen is less in the vertebral crush fracture group than in the control group. However, since these measurements represent an isolated point temporally removed from major changes in bone morphology, their exact relationship to the crush fracture and osteoporotic process remains uncertain.

KW - Androgen dynamics

KW - Estrogen dynamics

KW - Vertebral crush factors

UR - http://www.scopus.com/inward/record.url?scp=0021732930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021732930&partnerID=8YFLogxK

U2 - 10.1016/0378-5122(84)90002-1

DO - 10.1016/0378-5122(84)90002-1

M3 - Article

C2 - 6533434

AN - SCOPUS:0021732930

VL - 6

SP - 309

EP - 318

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 4

ER -